Eko Health announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized national payment for its Sensora platform.
Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 Day CGM.
Medtronic (NYSE: MDT)+
today announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the MiniMed 780G pump.
MannKind (Nasdaq:MNKD) announced that the FDA accepted a supplemental New Drug Application (sNDA) for its Furoscix ReadyFlow autoinjector.
The decision is supported by evidence from a clinical study and data from supporting analytical validation trials.
Neusoft Medical’s latest high-end systems are gaining rapid global traction, with installations rising worldwide
KIC Ventures began educating physicians to use the InSpan instrumentation system to carefully dissect around interspinous implants and remove them with minimal disruption
A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in postmenopausal women with obesity.
After a spinal cord injury, cells in the brain and spinal cord change to cope with stress and repair tissue. A new study from Karolinska Institutet, published in Nature Neuroscience, shows that this response is controlled by specific DNA sequences. This knowledge could help develop more targeted treatments.
Bill Janes is on a mission to improve life for people with amyotrophic lateral sclerosis (ALS). As a licensed occupational therapist and researcher at the University of Missouri, he’s seen firsthand how the disease can steal a person’s strength, speech and independence.